NATALI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 18.407
AS - Asia 9.797
EU - Europa 8.128
SA - Sud America 1.736
Continente sconosciuto - Info sul continente non disponibili 608
AF - Africa 356
OC - Oceania 34
Totale 39.066
Nazione #
US - Stati Uniti d'America 17.831
SG - Singapore 3.088
CN - Cina 2.518
FI - Finlandia 2.143
HK - Hong Kong 1.801
IT - Italia 1.756
BR - Brasile 1.427
SE - Svezia 956
VN - Vietnam 910
BG - Bulgaria 674
DE - Germania 561
GB - Regno Unito 462
FR - Francia 421
TR - Turchia 391
CA - Canada 387
RU - Federazione Russa 327
UA - Ucraina 237
JP - Giappone 162
IN - India 161
KR - Corea 159
SM - San Marino 139
BD - Bangladesh 119
AR - Argentina 117
IE - Irlanda 95
IQ - Iraq 88
MX - Messico 83
CH - Svizzera 79
CI - Costa d'Avorio 75
ZA - Sudafrica 52
AT - Austria 50
EC - Ecuador 49
ID - Indonesia 49
UZ - Uzbekistan 49
SN - Senegal 47
PK - Pakistan 46
ES - Italia 43
SA - Arabia Saudita 43
KE - Kenya 40
MA - Marocco 38
VE - Venezuela 38
NL - Olanda 36
PL - Polonia 35
CO - Colombia 34
AU - Australia 28
BE - Belgio 26
CL - Cile 23
PY - Paraguay 23
AE - Emirati Arabi Uniti 21
NG - Nigeria 21
EG - Egitto 20
JO - Giordania 18
TN - Tunisia 18
CZ - Repubblica Ceca 17
TT - Trinidad e Tobago 17
TW - Taiwan 17
NP - Nepal 16
JM - Giamaica 15
IR - Iran 14
DZ - Algeria 13
HN - Honduras 13
AL - Albania 12
IL - Israele 12
MY - Malesia 12
PH - Filippine 12
CR - Costa Rica 11
DO - Repubblica Dominicana 11
LB - Libano 11
PT - Portogallo 11
PE - Perù 10
PS - Palestinian Territory 10
UY - Uruguay 10
AZ - Azerbaigian 9
KZ - Kazakistan 9
LT - Lituania 8
OM - Oman 8
NI - Nicaragua 7
PA - Panama 7
SV - El Salvador 7
GR - Grecia 6
MN - Mongolia 6
RO - Romania 6
TH - Thailandia 6
BB - Barbados 5
BJ - Benin 5
BO - Bolivia 5
ET - Etiopia 5
NZ - Nuova Zelanda 5
RS - Serbia 5
AM - Armenia 4
DK - Danimarca 4
GE - Georgia 4
KW - Kuwait 4
PR - Porto Rico 4
BH - Bahrain 3
EU - Europa 3
GT - Guatemala 3
HU - Ungheria 3
KG - Kirghizistan 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 38.408
Città #
Ashburn 2.034
Helsinki 1.906
Singapore 1.789
Hong Kong 1.783
Fairfield 1.657
Woodbridge 1.362
Houston 1.017
Santa Clara 985
San Jose 934
Ann Arbor 904
Chandler 846
Dallas 707
Sofia 671
Seattle 657
Shanghai 631
Wilmington 552
Beijing 535
Cambridge 528
Milan 524
New York 442
Princeton 327
Boardman 325
Ottawa 274
Jacksonville 271
Lawrence 260
Los Angeles 252
Izmir 246
Medford 240
Ho Chi Minh City 224
Lauterbourg 215
Hefei 191
Serra 187
Nanjing 164
Seoul 154
Tokyo 143
Council Bluffs 142
Hanoi 138
Des Moines 114
São Paulo 111
Pisa 107
London 106
Florence 105
Istanbul 104
Paris 103
Redondo Beach 103
Buffalo 101
San Diego 93
Dearborn 81
Dong Ket 80
Nanchang 78
Abidjan 75
Frankfurt am Main 71
Bern 70
Lancaster 70
Munich 65
Dakar 47
Rio de Janeiro 47
Chicago 45
San Francisco 42
The Dalles 42
Kunming 41
Ogden 41
Changsha 40
Falls Church 40
Rome 40
Jüchen 39
Redwood City 39
Tashkent 39
Nairobi 36
Nuremberg 36
Shenyang 36
Da Nang 35
Hebei 35
Baghdad 34
Columbus 34
Tianjin 33
Turku 33
Haiphong 32
Lucca 32
Belo Horizonte 31
Dhaka 31
Curitiba 30
Vienna 30
Washington 30
Brasília 29
Warsaw 29
Phoenix 28
Toronto 28
Jiaxing 27
Johannesburg 27
Fuzhou 26
Hangzhou 26
Brooklyn 25
Düsseldorf 25
Norwalk 25
Orem 25
Atlanta 24
Boulder 24
Orange 23
Brussels 22
Totale 27.337
Nome #
ANF IN PRIMARY ALDOSTERONISM - EFFECT OF DIETARY NA+ AND POSTURAL CHANGES AND RELATIONSHIP WITH ALDOSTERONE 2.036
Prognostic Value Of 24-hour Ambulatory Blood Pressure And Heart Rate Patterns In Diabetes: A 20-year Longitudinal Analysis Of The Chronic Diabetes Complications And All-cause Mortality In Pisa From 1999 Onwards (CHAMP1ON) Study Cohort 503
Hypertension: a metabolic disorder? 280
Modulation of postprandial glycemic responses by noncarbohydrate nutrients provides novel approaches to the prevention and treatment of type 2 diabetes 251
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance 243
Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy 222
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study 216
Insulin resistance and hyperinsulinemia - No independent relation to left ventricular mass in humans 215
Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial. 212
Insulin resistance, adipose depots and gut: Interactions and pathological implications 210
Diabetes and high blood pressure 199
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 199
alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population 196
Effects of insulin on the kidney and the cardiovascular system 193
Dietary sodium change in primary aldosteronism. Atrial natriuretic factor, hormonal, and vascular responses. Hypertension. 191
Insulin: new roles for an ancient hormone 184
At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin Sensitivity 182
Effect of insulin on skeletal muscle metabolism in essential hypertension 181
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 179
The novel collagen matrikine, endotrophin, is associated with mortality and cardiovascular events in patients with atherosclerosis 179
Beta-cell function is associated with carotid intima-media thickness independently of insulin resistance in healthy individuals 177
Beta-cell function in obesity: effects of weight loss 176
Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene 174
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 173
Hypertension, insulin resistance, and diabetes 172
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach 172
Hyperinsulinemia and autonomic nervous system dysfunction in obesity - Effects of weight loss 172
Effect of acute hyperglycemia on insulin secretion in humans 171
Euglycemic clamp insulin sensitivity and longitudinal systolic blood pressure: role of sex 171
Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells. 170
Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data 170
Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study 170
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study 168
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 167
Endothelial dysfunction in type 2 diabetes 164
Early metabolic markers of the development of dysglycaemia and type 2 diabetes and their physiological significance 164
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies 162
Cardiovascular organ damage in type 2 diabetes mellitus: The role of lipids and inflammation 162
Assessment of insulin-glucose uptake dose-response characteristics in the non-steady state 161
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database 161
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 160
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 160
Intestinal glucose absorption is a key determinant of 1-hour postload plasma glucose levels in nondiabetic subjects 160
Insulino Resistenza e Flusso Ematico: Studi con L'Adenosina in Pazienti con Ipertensione Essenziale 158
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects 158
Glucose uptake saturation explains glucose kinetics profiles measured by different tests 158
OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions 158
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: A European cross-sectional study 157
Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database. 156
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” 156
Cardiac Reserve and Exercise Capacity: Insights from Combined Cardiopulmonary and Exercise Echocardiography Stress Testing 156
Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study 155
Effect of insulin on skeletal muscle metabolism in essential hypertension 154
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients 154
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects The RISC Study 154
Relation of large artery remodelling and distensibility to insulin-resistance in patients with type 2 diabetes 153
Family history of diabetes predisposes to cardiovascular disease among patients with type 2 diabetes: What is the nature of the association? 152
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance 151
A mixed nutrient preload attenuates glucose-induced endothelial dysfunction in individuals with abnormal glucose tolerance 148
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality 147
Coronary artery disease and stroke in type 2 diabetic patients: possible role of a raised central pulse pressure 147
A novel fasting blood test for insulin resistance and prediabetes 146
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study 145
Measurement of insulin-mediated glucose uptake: Direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp 144
Autonomic and hemodynamic responses to insulin in lean and obese humans 143
Impaired insulin action on skeletal muscle metabolism in essential hypertension 143
Reciprocal association between insulin sensitivity and the haematocrit in man 143
Carotid artery remodeling and compliance, insulin resistance, and lipid metabolism in type 2 diabetic patients. 142
Critical evaluation of the questionnaires assessing adherence to the Mediterranean diet that are based on servings 142
Influence of endogenous NEFA on beta cell function in humans 141
The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides 140
Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes 140
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy RID F-2315-2010 139
Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. 139
A short-term increase in dietary cholesterol and fat intake affects high-density lipoprotein composition in healthy subjects 138
Effects of angiotensin-converting enzyme inhibition on carbohydrate metabolism and insulin sensitivity in hypertensive patients 137
Insulin sensitivity and fasting insulin: association with indicators of cardiovascular disease in healthy subjects. The RISC Study 137
Association of fasting glucagon and proinsulin concentrations with insulin resistance 137
Insulin resistance, insulin response, and obesity as indicators of metabolic risk 137
Effect of a reduced-fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hypercholesterolemia 136
Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction 135
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications 134
Insulin-resistance and triglycerides as independent predictors of the early macrovascular involvement in type 2 diabetic patients 134
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 134
Renovascular hypertension and insulin sensitivity 133
Insulin resistance of stress: Sites and mechanisms 133
A genome-wide association study of IVGTT-based measures of first-phase insulin secretion refines the underlying physiology of type 2 diabetes variants 133
Effects of Mild Acute Hypertriglyceridemia on Fasting and Post-Load Glucose Homeostasis 133
Muscle metabolism and exercise tolerance in subclinical hypothyroidism: A controlled trial of levothyroxine 132
Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study 132
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 131
Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents 131
Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial 130
EFFECTS OF INSULIN ON HEMODYNAMICS AND METABOLISM IN HUMAN FOREARM 130
Role of Glycosuria in SGLT2 Inhibitor–Induced Cardiorenal Protection: A Mechanistic Analysis of the CREDENCE Trial 129
Metabolic effects of combined antihypertensive treatment in patients with essential hypertension 129
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease. 129
LDL resistance to copper-induced oxidation: Effect of LDL lipid composition 128
Increased gluconeogenesis in NIDDM: Substrate contribution and modulation by lipolysis 127
EFFECT OF INSULIN ON URIC-ACID EXCRETION IN HUMANS 127
Totale 18.193
Categoria #
all - tutte 117.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.914


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.847 0 145 115 224 534 392 63 171 132 52 150 869
2022/20232.759 400 317 178 201 303 359 23 219 482 32 208 37
2023/20242.458 270 273 334 182 375 421 82 71 46 42 85 277
2024/20258.028 52 331 76 326 635 952 610 484 913 1.107 831 1.711
2025/202611.135 731 1.195 1.075 958 860 906 1.133 472 2.362 832 349 262
2026/2027750 366 384 0 0 0 0 0 0 0 0 0 0
Totale 39.066